Make Informed Investment Decisions with Affordable Access to Experts
Discussing Zolgensma with a clinician who has prescribed the drug to a patient since launch, after recent news of data manipulation has come to surfaceTicker(s): NVS, BIIB
Name: Dr Farida Abid - MD
Institution: Baylor College of Medicine / Texas Children's Hospital
- Specialist in neuromuscular disorders, with experience in multiple clinical trials focused on various Muscular Dystrophies.
- Currently manages 36 patients with SMA.
- Her center has administered Zolgensma to a patient since approval.
What is your initial experience using Zolgensma in patients?Added By: joe_mccann
How much have you followed the recent headlines on data manipulation? How has that impacted your view of Zolgensma?Added By: joe_mccann
What questions are parents asking about gene therapy? How are you managing discussions with parents about the lack of long-term data on Zolgensma?Added By: catherineb
What convinces her that Risdiplam, Zolgensma and Spinraza have equivalent efficacy?Added By: catherineb
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.